PubMed

商業用AI合成CT生成器の脳・前立腺MRのみの放射線治療における画像評価

PMID: 42547906 · 2026

M, o, r, g, a, n, , A, i, r, e, ;, , C, a, r, s, o, n, , M, a, t, t, h, e, w, s, ;, , J, o, s, h, u, a, , J, o, n, e, s, ;, , D, a, v, i, d, , D, u, o, n, g, ;, , C, h, r, i, s, t, o, p, h, e, r, , S, c, h, n, e, i, d, e, r, ;, , S, o, t, i, r, i, o, s, , S, t, a, t, h, a, k, i, s, ;, , O, l, i, v, i, a, , S, h, a, y, ;, , K, r, y, s, t, a, l, , K, i, r, b, y

学術誌Journal of applied clinical medical physics

年2026

PMID42547906

抄録

Synthetic CTs (sCT) were developed to provide electron density information for MR-only treatment planning. Some AI-based sCT generators have received FDA-clearance and better capture tissue heterogeneity through voxel-wise mappings to improve image guidance and dose calculation. To quantitatively characterize the image quality and geometric surrogate agreement of an FDA 510(k) cleared AI-based synthetic CT generator (TheraPanacea) for brain and prostate MR-only radiotherapy, using per-structure

公式ソース

PubMedで見る →

データはPubMed / NCBIから取得しています。全文および最新情報は必ず公式記録をご確認ください。